Once we demonstrated that HDAC6 is overexpressed at the RNA and protein level in GBM, we performed immunohistochemistry against HDAC6 in healthy brain sections and in GBM sections from the Hospital Complex of Navarra. Here, HDAC6 is linked to glioblastoma.